Long-term outcomes of patients with conserved breast cancer treated with adjuvant hypofractionated prone breast intensity-modulated radiation therapy.
Aron M GortmanNoel J AherneJulan AmalaseelanAndrew LastJustin WesthuyzenLauren ChamberlainThomas P ShakespearePublished in: Journal of medical imaging and radiation oncology (2020)
Adjuvant hypofractionated prone breast IMRT has excellent locoregional control and minimal toxicity.